OQS
INSM icon

Occudo Quantitative Strategies’s Insmed INSM Stock Holding History

Occudo Quantitative Strategies’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,234
Closed -$222K – 1303
2022
Q2 		$222K Buy
+11,234
New +$235K 0.02% 886

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Occudo Quantitative Strategies's INSM Position: Q3 2022 in Review

Occudo Quantitative Strategies sold out of Insmed (INSM) in Q3 2022, closing a stake of 11,234 shares — an estimated $222K sold.

Occudo Quantitative Strategies first reported a position in INSM in Q2 2022 and held it in 1 quarter. The position peaked at $222K in Q2 2022. 238 funds tracked by Wall St. Rank hold INSM as of Q3 2022.

  • Occudo Quantitative Strategies reported no remaining Insmed position as of Q3 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 11,234 Insmed shares in Q3 2022, an estimated $222K.
  • Occudo Quantitative Strategies first reported a position in Insmed in Q2 2022 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Insmed position peaked at $222K in Q2 2022.
  • 238 funds tracked by Wall St. Rank held Insmed as of Q3 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.